Vaccines, Blood & Biologics

Science & Research (Biologics)

Blood cells

Research is fundamental to FDA's ability to provide effective regulatory review of biological products. A wide variety of rapidly evolving technical and scientific issues concerning the safety, potency, and efficacy of new biological products requires knowledge of new developments in basic research in the relevant biological disciplines.

For this reason, FDA scientists in our Center for Biologics Evaluation and Research (CBER) conduct a variety of mission-related programs, including research into allergenics, blood, cellular and gene therapy, and vaccines, to name a few. This research broadens FDA's knowledge of fundamental biological processes and provides a robust scientific base for regulatory review.

In this Web section you will find information on some of the research programs conducted by CBER scientists and their published scientific articles.

CBER also offers research job opportunities in the form of research fellowships and staff positions.

Biologics Research Projects

Approvals & Clearances

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 03/26/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English